secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNBX Pharmaceuticals Inc. (CNBX)
CIK:        0001343009
Form:       8-K
Filed at:   2026-03-17T23:59:59+00:00
Accession:  0001683168-26-001883
Event type: debt
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CNBX Pharmaceuticals issues $45K promissory note to 3i L.P. for working capital
-------------------------------------------------------------------------------

- Non-convertible note principal $45,000, due July 1, 2026, with 5% simple interest.
- Proceeds used for immediate working capital needs.
- Holder may exchange 120% of outstanding balance for equity in a future financing at the lowest price.
- Payments include a 20% premium; note may be prepaid on two days' notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1343009/000168316826001883/0001683168-26-001883-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1343009/000168316826001883/cnbx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-001883

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer